Tylenol and Band-Aid maker Johnson & Johnson announced on Tuesday that its sales declined 0.7% to $15 billion in the third quarter, compared to the same quarter last year, as domestic sales were “significantly impacted” by recent successive recalls. Domestic sales declined 2.5%.
Continue reading Johnson & Johnson Earnings Hurt by Children’s Medicine Recalls
Johnson & Johnson Earnings Hurt by Children’s Medicine Recalls originally appeared on DailyFinance on Tue, 19 Oct 2010 10:55:00.
Filed Under: Company News, Health Care, Earnings, Johnson & Johnson, Stocks in the News